# Junta clínica — PT-pseudo_926c37508fe2 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_926c37508fe2",
  "pid": "PT-pseudo_926c37508fe2",
  "task": 1,
  "psa": 5.4,
  "age": 67,
  "months": 2,
  "pirads": "2",
  "psad": 0.143,
  "psav": 0.96,
  "psap": 4.2,
  "vol": 37.82,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.7259888,
  "medhx": "Hypercholesterolaemia, Chronic kidney disease, Osteoarthritis, Benign prostatic hyperplasia",
  "meds": "simvastatin, rosuvastatin, paracetamol PRN, tamsulosin",
  "notes": "PSA 5.4 ng/mL. PI-RADS 2. PSAD 0.14. Prostate volume 38 mL. csPCa 0.73.",
  "pmhx": [
    "Hypercholesterolaemia",
    "Chronic kidney disease",
    "Osteoarthritis",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [
    "Iodinated contrast (mild)"
  ],
  "vitals": {
    "weight": "78 kg",
    "height": "175 cm",
    "bmi": "25.5",
    "bp": "115/59 mmHg",
    "hr": "60 bpm",
    "smoking": "Current smoker (39 pack-yr)",
    "last_dental": "1 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "27 Jan 2025",
  "enc_ref": "Dr. R. van den Berg (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Seeking specialist reassessment due to escalating PSA levels and a prior biopsy bucket Positive."
    },
    {
      "s": "History",
      "t": "A 67-year-old retired civil servant with a established urological background, first brought to clinical attention by an incidental PSA rise in 2023. He currently smokes and carries a 39 pack-year history. Moderate lower urinary tract symptoms are present, currently controlled with tamsulosin and paracetamol PRN, yielding an IPSS score of 12. His urological record documents a prior biopsy in 2023 that confirmed ISUP GG 2 adenocarcinoma. Systemic health includes hypercholesterolaemia, chronic kidney disease, and osteoarthritis, managed with simvastatin and rosuvastatin. He maintains an alcohol-free lifestyle, dedicates his time to gardening, and lives alone despite being married. Recent clinical engagements feature endocrinology-led thyroid screening, six physiotherapy sessions addressing stable lower back discomfort, and an orthopaedic review for knee osteoarthritis. He voices considerable apprehension about invasive procedures and has asked for detailed explanations regarding any potential interventions."
    },
    {
      "s": "Physical examination",
      "t": "DRE: The prostate presents as symmetrically enlarged with a smooth, homogeneous consistency, lacking palpable nodules or asymmetry. Vital signs remain stable, recording a blood pressure of 115/59 mmHg and a regular heart rate of 60 bpm. General examination is unremarkable, with clear lung fields and a soft, non-tender abdomen."
    }
  ],
  "occupation": "retired civil servant",
  "marital": "Married",
  "living": "Lives alone",
  "next_of_kin": "Sibling (sister)",
  "recent_other": [
    "Endocrine — thyroid screening",
    "Physiotherapy — lower back, six sessions",
    "Orthopaedic outpatient — knee follow-up"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Gardening, no structured exercise",
  "ipss": "IPSS score: 12/35 (moderate LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Ziekenhuis Gelderse Vallei (Ede)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_926c37508fe2
Task: 1

Encounter: Urology - outpatient on 27 Jan 2025.
Referrer: Dr. R. van den Berg (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 67-year-old male
  - PSA: 5.4 ng/mL
  - mpMRI — PI-RADS score: 2 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.143 ng/mL²
  - PSA velocity: 0.96 ng/mL/yr
  - Prior PSA: 4.2 ng/mL
  - Prostate volume: 37.82 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7259888 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypercholesterolaemia, Chronic kidney disease, Osteoarthritis, Benign prostatic hyperplasia
  - Problem list / PMHx: Hypercholesterolaemia, Chronic kidney disease, Osteoarthritis, Benign prostatic hyperplasia
  - Current medication: simvastatin, rosuvastatin, paracetamol PRN, tamsulosin
  - Allergies: Iodinated contrast (mild)
  - Additional notes: PSA 5.4 ng/mL. PI-RADS 2. PSAD 0.14. Prostate volume 38 mL. csPCa 0.73.

Vitals: weight 78 kg, height 175 cm, BMI 25.5, BP 115/59 mmHg, HR 60 bpm. Smoking: Current smoker (39 pack-yr).

Chief complaint: Seeking specialist reassessment due to escalating PSA levels and a prior biopsy bucket Positive.

History: A 67-year-old retired civil servant with a established urological background, first brought to clinical attention by an incidental PSA rise in 2023. He currently smokes and carries a 39 pack-year history. Moderate lower urinary tract symptoms are present, currently controlled with tamsulosin and paracetamol PRN, yielding an IPSS score of 12. His urological record documents a prior biopsy in 2023 that confirmed ISUP GG 2 adenocarcinoma. Systemic health includes hypercholesterolaemia, chronic kidney disease, and osteoarthritis, managed with simvastatin and rosuvastatin. He maintains an alcohol-free lifestyle, dedicates his time to gardening, and lives alone despite being married. Recent clinical engagements feature endocrinology-led thyroid screening, six physiotherapy sessions addressing stable lower back discomfort, and an orthopaedic review for knee osteoarthritis. He voices considerable apprehension about invasive procedures and has asked for detailed explanations regarding any potential interventions.

Physical examination: DRE: The prostate presents as symmetrically enlarged with a smooth, homogeneous consistency, lacking palpable nodules or asymmetry. Vital signs remain stable, recording a blood pressure of 115/59 mmHg and a regular heart rate of 60 bpm. General examination is unremarkable, with clear lung fields and a soft, non-tender abdomen.

Patient info: retired civil servant; Married; Lives alone.
Next of kin: Sibling (sister).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Gardening, no structured exercise; IPSS score: 12/35 (moderate LUTS).

Recent other appointments: Endocrine — thyroid screening; Physiotherapy — lower back, six sessions; Orthopaedic outpatient — knee follow-up.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.47
  uncertainty  +/- 0.14 epistemic (95% band 0.19-0.75); among patients I cannot tell apart the outcome was 1.00 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 4 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 67 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 5.4 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 37.82 mL (1% of my signal; from log_vol, vol) · PSA density = 0.143 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.73 (1% of my signal; from cspca) · PI-RADS = 2 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. My criterion answers DEFER.

The criterion: PI-RADS 1-2 on the current mpMRI: there is no lesion to sample. In the labelled series this criterion matched the reading urologist in 2 of 2 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 2
  important  prior biopsy = Positive
  noted      age = 67 · DRE = Normal · PSA = 5.4 ng/mL · prostate volume = 37.82 mL · PSA density = 0.143 · comorbidity = 4 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 2 of 2 labelled cases

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 49 men I have seen in this same situation (Positive prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 0.42: PI-RADS 2, PSA 4.7, PSAD 0.14, age 67, DRE Normal -> DEFER (clear). He wrote: "Priads 2 with only sightly elevated PSA"
  2. distance 1.69: PI-RADS 2, PSA 8.3, PSAD 0.206, age 66, DRE Nodus -> DEFER (clear). He wrote: "Patient with low-risk cancer on active surveillance. Now normal MRI."
  3. distance 2.05: PI-RADS 3, PSA 7.7, PSAD 0.11, age 64, DRE Normal -> DEFER (borderline). He wrote: "Low risk PC with PSA <10. No red flags on biopsy or MRI, reasonably low PSA density. MRI finding minor and probably penetrated by systematic biopsy core (peripheral zone…"

PRECEDENT: DEFER (weighted vote 0.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 2
  important  PSA = 5.4 ng/mL
  noted      family history = not opened (0 of 91) · age = 67 · DRE = Normal · prostate volume = 37.82 mL · PSA density = 0.143 · comorbidity = 4 on the problem list
  not used   prior biopsy, csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 67 · PSA = 5.4 ng/mL · PI-RADS = 2
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 37.82 mL · PSA density = 0.143 · comorbidity = 4 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines address the use of MRI findings and PSA density in guiding biopsy decisions. "A stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous but it might be excluded in patients with low-risk tumour and a stable low PSA-D < 0.15." This suggests that a PI-RADS 2 finding with a PSA density of 0.143 falls into a category where biopsy might be excluded if the tumor is low-risk.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of NO BIOPSY is weighed against the guideline's context regarding PSA density and MRI stability. The guideline suggests that a stable MRI with a low PSA-D (< 0.15) might exclude biopsy for low-risk disease. The fact the guideline needs that no panel variable represents the prior biopsy status, as the guideline does not specify the action based on a prior positive biopsy.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy: at Positive the guideline does not specify the action, but the context suggests a prior positive biopsy is a significant factor.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the PSA velocity of 0.96 ng/mL/yr is a factor that the guideline may use to assess disease progression.
laboratory_results - the laboratory results: the PSA density of 0.143 ng/mL/cc is a specific value that the guideline uses in its risk-adapted matrix.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on whether the PI-RADS 2 finding and low PSA density, in the context of a prior positive biopsy, are sufficient to defer biopsy according to the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What does the PSA velocity of 0.96 ng/mL/yr suggest regarding disease progression?
  previous_notes (get_previous_notes) -> What is the management context, including the prior biopsy grade, surveillance protocol, and planned intervention?
  laboratory_results (get_lab_results) -> What is the specific value of the PSA density (0.143 ng/mL/cc) and how does it factor into the risk assessment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What should be established regarding the lesion comparison in the radiology_report?
  Q2. What should be established regarding the PSA velocity in the psa_trend?
  Q3. What should be established regarding the management context and surveillance plan in the previous_notes?
  Q4. What should be established regarding the PSA density value in the laboratory_results?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
COMPARISON: new
LESION: size and zone of the index lesion, as the report words it: "No PI-RADS 3+ lesion identified."

psa_trend
What does the PSA velocity of 0.96 ng/mL/yr suggest regarding disease progression?: The PSA velocity of 0.96 ng/mL/yr suggests disease progression.

previous_notes
What is the management context, including the prior biopsy grade, surveillance protocol, and planned intervention?: The management context includes a prior biopsy grade of ISUP GG 2 adenocarcinoma, and the surveillance protocol was initiated following the positive biopsy.

laboratory_results
What is the specific value of the PSA density (0.143 ng/mL/cc) and how does it factor into the risk assessment?: The specific value of the PSA density is 0.143 ng/mL/cc, which factors into the risk assessment by being a specific value used in the risk-adapted matrix.

WHAT I DID NOT OPEN
family-history anamnesis, because it was not required by the plan and its absence does not change the immediate decision path.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 2 finding, as per EXPERT-COHORT, suggests no lesion to sample.
PSA velocity of 0.96 ng/mL/yr, as per EXPERT-EAU, is a factor that the guideline may use to assess disease progression.

AGAINST sampling this patient now
Prior biopsy was Positive, as per EXPERT-COHORT, which suggests a strong factor against immediate re-biopsy.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 5.40 ng/mL over 4 points spanning 20 months; velocity +1.89 ng/mL per year; doubling time about 16 months.
PROJECTION at 6 months: 7.4 ng/mL, conformal 95% band 2.1-25.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 5.4 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.33
  uncertainty  +/- 0.12 epistemic (95% band 0.09-0.56), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 2 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 5.4 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 37.82 mL (4% of my signal; from log_vol, vol) · PSA density = 0.143 (0% of my signal; from psad_calc) · comorbidity = 4 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.47  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.33  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-EXPERIENCE  DEFER, p(biopsy)=0.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      DEFER  (rule pirads_le_2; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_le_2) — carried by EXPERT-COHORT.
PANEL ANSWER: NO BIOPSY. It matched the reading urologist in 2 of 2 labelled cases in exactly this situation (prior positive biopsy).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:— E2:—              -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          67                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          5.4 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          37.82 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.143                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.73                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       2                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> important
  comorbidity  4 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened appear to answer the moderator's questions, as the trace model listed all documents that were opened, and no document listed by the trace model remained unopened.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of NO BIOPSY, as the cohort criterion (PI-RADS $\le 2$) fired, which is the rule that led to the panel's decision.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What should be established regarding the lesion comparison in the radiology_report? The report states "COMPARISON: new."
Q2. What should be established regarding the PSA velocity in the psa_trend? The PSA velocity of 0.96 ng/mL/yr suggests disease progression.
Q3. What should be established regarding the management context and surveillance plan in the previous_notes? The context includes a prior biopsy grade of ISUP GG 2 adenocarcinoma, and the surveillance protocol was initiated following the positive biopsy.
Q4. What should be established regarding the PSA density value in the laboratory_results? The specific value is 0.143 ng/mL/cc, which factors into the risk assessment by being a specific value used in the risk-adapted matrix.

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: Positive: decisive, because it was a key factor weighted by EXPERT-STRUCTURED and EXPERT-COHORT, strongly arguing against immediate biopsy. I agree with the PANEL-PROTOCOL's decision to defer based on this.
<pirads>: 2: decisive, because the cohort criterion fired based on this finding, which is the primary driver for the panel's decision. I agree with the PANEL-PROTOCOL's decision.
<psa>: 5.4 ng/mL: important, as it was noted by multiple experts, but it did not overturn the deferral decision. I agree with the PANEL-PROTOCOL's decision.
Confidence: clear.

MY SUGGESTION TO THE CHAIR
I suggest deferral, as the evidence retrieved confirms the cohort criterion that supports the panel's decision, despite the rising PSA velocity.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: clear)

67y male, PSA 5.4, PSAD 0.143, PI-RADS 2, prior positive biopsy. Stable PI-RADS 2 and low PSAD argue against further biopsy given the low-risk profile. The decision is to follow PSA and re-image if it rises.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
